ReNerve Limited

ASX:RNV Stock Report

Market Cap: AU$19.2m

ReNerve Valuation

Is RNV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RNV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate RNV's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate RNV's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RNV?

Key metric: As RNV barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for RNV. This is calculated by dividing RNV's market cap by their current book value.
What is RNV's PB Ratio?
PB Ratio2.6x
BookAU$7.42m
Market CapAU$19.17m

Price to Book Ratio vs Peers

How does RNV's PB Ratio compare to its peers?

The above table shows the PB ratio for RNV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average2.4x
LDX Lumos Diagnostics Holdings
2.3xn/aAU$24.6m
NXS Next Science
3.8x47.6%AU$41.6m
VTI Visioneering Technologies
1.2xn/aAU$7.7m
OSX Osteopore
2.4xn/aAU$4.3m
RNV ReNerve
2.6xn/aAU$19.2m

Price-To-Book vs Peers: RNV is expensive based on its Price-To-Book Ratio (2.6x) compared to the peer average (2.4x).

Price to Book Ratio vs Industry

How does RNV's PB Ratio compare vs other companies in the AU Medical Equipment Industry?

3 CompaniesPrice / BookEstimated GrowthMarket Cap
OSP Osprey Medical
0.7xn/aUS$3.57m
OVN Oventus Medical
0.6xn/aUS$3.31m
VIP VIP Gloves
0.2xn/aUS$1.56m
No more companies available in this PB range
RNV 2.6xIndustry Avg. 2.8xNo. of Companies8PB02.85.68.411.214+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: RNV is good value based on its Price-To-Book Ratio (2.6x) compared to the Australian Medical Equipment industry average (2.8x).

Price to Book Ratio vs Fair Ratio

What is RNV's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RNV PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio2.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate RNV's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Doctor Care Anywhere Group

AU$25.3m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.07

7D

4.5%

1Y

45.8%

CardieX

AU$32.4m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.11

7D

-24.1%

1Y

n/a

Cogstate

AU$170.8m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$0.99

7D

4.2%

1Y

-35.5%